The evolving role of nuclear medicine in differentiating pseudoprogression from tumor progression in gliomas.
PURPOSE OF REVIEW Gliomas remain associated with poor outcomes, despite multimodal treatment. Response assessment relies primarily on MRI; however, treatment-related changes (TRC), particularly pseudoprogression (psPD), may mimic tumor progression disease (PD), creating a major diagnostic challenge. This review focuses...